Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Type 1 diabetes mellitus].

E Larger1, D Dubois-Laforgue, J Timsit

  • 1Service de Diabétologie, Hôpital Bichat, Paris. etienne.larger@bch.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monogenic diabetes in adults: A multi-ancestry study reveals strong disparities in diagnosis rates and clinical presentation.

Diabetes research and clinical practice·2022
Same author

Anaemia and its risk factors and association with treatments in patients with diabetes: A cross-sectional study.

Diabetes & metabolism·2020
Same author

Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery.

Diabetes & metabolism·2019
Same author

High frequency of transaminase elevation following diabetic ketoacidosis.

Diabetes & metabolism·2019
Same author

Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.

Diabetes & metabolism·2019
Same author

[Diagnostic and therapeutic recommendations for sexually transmitted diseases: Genital herpes].

Annales de dermatologie et de venereologie·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Type 1 diabetes mellitus diagnosis requires autoantibody screening in all diabetic patients, regardless of insulin dependence. Early detection and intervention during the preclinical phase are crucial for preventing chronic hyperglycemia and improving metabolic control.

Area of Science:

  • Immunology and Endocrinology
  • Metabolic Disorders
  • Autoimmune Diseases

Background:

  • Type 1 diabetes mellitus (T1DM) is characterized by specific autoantibodies, distinguishing it from other causes of chronic hyperglycemia.
  • T1DM can present as either insulin-dependent or non-insulin-dependent, complicating initial diagnosis.
  • The pathophysiology involves genetic and environmental factors leading to immune tolerance breakdown.

Purpose of the Study:

  • To emphasize the necessity of autoantibody screening in all diabetes mellitus patients for accurate diagnosis and prediction of insulin dependence.
  • To highlight the importance of identifying associated autoimmune diseases.
  • To underscore the potential for early intervention during the preclinical phase.

Main Methods:

Related Experiment Videos

  • Review of diagnostic criteria and pathophysiology of diabetes mellitus.
  • Discussion of the role of autoantibodies in T1DM.
  • Exploration of preclinical phase markers and secondary prevention strategies.

    • Main Results:

    • Autoantibody detection is essential for all diabetes diagnoses to differentiate T1DM and predict insulin dependence.
    • A long preclinical phase exists, marked by immune system activation, offering a window for intervention.
    • Simplified autoantibody detection techniques support large-scale screening initiatives.

    Conclusions:

    • Universal autoantibody screening in diabetes patients is recommended for accurate diagnosis and management.
    • Early intervention during the preclinical phase, guided by immune activation signs, is key for secondary prevention.
    • Intensive insulin therapy at diagnosis aids in preserving beta-cell function and achieving long-term metabolic control.